Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current Treatment Options in Raynaud's Phenomenon.

Sergio Generini1, Angela Del Rosso, Alberto Pignone

  • 1Section of Rheumatology, Department of Internal Medicine, University of Florence, Viale Pieraccini, 18-50139 Florence, Italy. generini@hotmail.com

Current Treatment Options in Cardiovascular Medicine
|April 11, 2003
PubMed
Summary

Raynaud

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Personalized Care Through Multidisciplinary Management in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Narrative Review.

Journal of personalized medicine·2026
Same author

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

RMD open·2026
Same author

Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.

Journal of autoimmunity·2026
Same author

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Arthritis care & research·2025
Same author

Cellular Players in Gastrointestinal Involvement of Systemic Sclerosis: Insights into Pathogenesis.

Cells·2025
Same author

Adenomyosis in patients with rheumatic diseases: a cross-disciplinary clinical observation.

Frontiers in reproductive health·2025

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Dermatology

Background:

  • Raynaud's phenomenon (RP) is a condition characterized by exaggerated vasoconstriction of peripheral arteries, typically affecting the fingers and toes.
  • Treatment strategies for RP are contingent upon symptom severity and the presence of underlying systemic diseases, necessitating thorough patient evaluation.
  • Primary RP management often begins with conservative, non-pharmacological interventions, with medication considered if symptoms persist.

Purpose of the Study:

  • To outline current therapeutic approaches for Raynaud's phenomenon.
  • To emphasize the importance of assessing for secondary causes of RP.
  • To highlight the role of vasodilating drugs and explore potential novel therapeutic avenues.

Main Methods:

  • Review of current literature on Raynaud's phenomenon treatment.
  • Clinical assessment guidelines for patients with RP.
  • Pharmacological treatment strategies including lifestyle modifications and drug therapies.

Main Results:

  • Treatment is tailored to RP severity and underlying conditions.
  • Non-pharmacologic measures (cold avoidance, smoking cessation) are primary interventions.
  • Vasodilating drugs, such as calcium channel blockers, remain the cornerstone of medical therapy.

Conclusions:

  • Comprehensive assessment is crucial for all RP patients to identify underlying diseases.
  • Lifestyle modifications and vasodilating pharmacotherapies are the current mainstays of RP management.
  • Further research is needed to confirm the efficacy of novel therapies, including antioxidant agents, for endothelial damage and other pathogenetic processes.

Related Experiment Videos